We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SAVA market cap is 112.58M. The company's latest EPS is USD -2.0207 and P/E is -0.01.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -27.88M | -22.79M | -19.93M | -61.65M | -30.62M |
| Net Income | -25.65M | -20.92M | -18.75M | 49.95M | -27.94M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.96M | -6.79M | -32.87M | -80.02M | -105.96M |
| Net Income | -4.63M | -6.33M | -32.39M | -76.25M | -97.22M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 172.53M | 151.66M | 155.72M | 243.57M | 223.75M |
| Total Liabilities | 17.41M | 14.2M | 77.12M | 54.59M | 57.11M |
| Total Equity | 155.12M | 137.47M | 78.6M | 188.97M | 166.64M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23.49M | 94.3M | 266.78M | 234.83M | 151.66M |
| Total Liabilities | 1.39M | 2.1M | 12.87M | 7.3M | 14.2M |
| Total Equity | 22.1M | 92.2M | 253.92M | 227.54M | 137.47M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -59.71M | -82.03M | -19.13M | -37.37M | -55.66M |
| Investing | -373k | -414k | N/A | -29k | -46k |
| Financing | 1.42M | 2.56M | 22.16M | 123.55M | 123.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.51M | -5.38M | -30.2M | -77.51M | -82.03M |
| Investing | -18k | 360k | -22.21M | -2.71M | -414k |
| Financing | 5.81M | 75.45M | 192.34M | 47.8M | 2.56M |
| Market Cap | 112.58M |
| Price to Earnings Ratio | -0.01 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.01 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | - |
| Shares Outstanding | 48.11M |
| Average Volume (1 week) | 3.26M |
| Average Volume (1 Month) | 7.93M |
| 52 Week Change | -90.32% |
| 52 Week High | 42.20 |
| 52 Week Low | 2.23 |
| Spread (Intraday) | 0.03 (1.27%) |
| Company Name | Cassava Sciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.cassavasciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
